Randomized Comparison of the Nobori Biolimus A9-Eluting Coronary Stent With the Taxus Liberté Paclitaxel-Eluting Coronary Stent in Patients With Stenosis in Native Coronary Arteries. The NOBORI 1 Trial—Phase 2 - Chevalier, C; Silber, S; Park, SJ (Circulation: Cardiovascular Interventions, 2009)